• 9921 Citations
  • 49 Scopus h-Index
20012019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2001 2019

Filter
Article
2019
6 Citations (Scopus)

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2019

Wierda, W. G., Byrd, J. C., Abramson, J. S., Bilgrami, S. F., Bociek, G., Brander, D., Brown, J., Chanan Khan, A. A., Chavez, J. C., Coutre, S. E., Davis, R. S., Fletcher, C. D., Hill, B., Kahl, B. S., Kamdar, M., Kaplan, L. D., Khan, N., Kipps, T. J., Ma, S., Malek, S. & 9 others, Mato, A., Mosse, C., Neppalli, V. T., Shadman, M., Siddiqi, T., Stephens, D., Wagner, N., Dwyer, M. A. & Sundar, H., Jan 1 2019, In : JNCCN Journal of the National Comprehensive Cancer Network. 17, 1, p. 12-20 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Lymphoma, Large B-Cell, Diffuse
Hodgkin Disease
Lymphoma
Guidelines
1 Citation (Scopus)

IGH translocations in chronic lymphocytic leukemia: Clinicopathologic features and clinical outcomes

Fang, H., Reichard, K. K., Rabe, K. G., Hanson, C. A., Call, T. G., Ding, W. D., Kenderian, S., Muchtar, E., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Slager, S. L., Braggio, E. D., Smoley, S. A., Kay, N. E., Shanafelt, T. D., Van Dyke, D. L. & Parikh, S. A., Jan 1 2019, (Accepted/In press) In : American Journal of Hematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
Therapeutics
Databases
5 Citations (Scopus)

Indatuximab Ravtansine (BT062) Monotherapy in Patients With Relapsed and/or Refractory Multiple Myeloma

Jagannath, S., Heffner, L. T., Ailawadhi, S., Munshi, N. C., Zimmerman, T. M., Rosenblatt, J., Lonial, S., Chanan Khan, A. A., Ruehle, M., Rharbaoui, F., Haeder, T., Wartenberg-Demand, A. & Anderson, K. C., Jan 1 2019, In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Appointments and Schedules
Neoplasms
2 Citations (Scopus)

Long-Term Studies Assessing Outcomes of Ibrutinib Therapy in Patients With Del(11q) Chronic Lymphocytic Leukemia

Kipps, T. J., Fraser, G., Coutre, S. E., Brown, J. R., Barrientos, J. C., Barr, P. M., Byrd, J. C., O'Brien, S. M., Dilhuydy, M. S., Hillmen, P., Jaeger, U., Moreno, C., Cramer, P., Stilgenbauer, S., Chanan-Khan, A. A., Mahler, M., Salman, M., Eckert, K., Solman, I. G., Balasubramanian, S. & 6 others, Cheng, M., Londhe, A., Ninomoto, J., Howes, A., James, D. F. & Hallek, M., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Open Access
B-Cell Chronic Lymphocytic Leukemia
Outcome Assessment (Health Care)
Disease-Free Survival
Therapeutics
Survival

Monoclonal antibody utilization characteristics in patients with multiple myeloma

Ailawadhi, S., Sher, T., Azzouqa, A. G., Meghji, Z., Jain, T., Jani, P., Ahmed, S., Diehl, N., Roy, V., Shah, V., Hodge, D., Ailawadhi, M., Alegria, V. R., Paulus, A., Chanan Khan, A. A. & Fonseca, R., Sep 1 2019, In : Anti-cancer drugs. 30, 8, p. 859-865 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Monoclonal Antibodies
Premedication
Clinical Trials
Drug Utilization
12 Citations (Scopus)
Multiple Myeloma
Dexamethasone
United States Food and Drug Administration
Disease-Free Survival
Myocarditis
4 Citations (Scopus)

Phase I study of the anti-FcRH5 antibody-drug conjugate DFRF4539A in relapsed or refractory multiple myeloma

Stewart, A. K., Krishnan, A. Y., Singhal, S., Boccia, R. V., Patel, M. R., Niesvizky, R., Chanan Khan, A. A., Ailawadhi, S., Brumm, J., Mundt, K. E., Hong, K., McBride, J., Shon-Nguyen, Q., Xiao, Y., Ramakrishnan, V., Polson, A. G., Samineni, D., Leipold, D., Humke, E. W., McClellan, J. S. & 1 others, Berdeja, J. G., Feb 1 2019, In : Blood cancer journal. 9, 2, 17.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Anti-Idiotypic Antibodies
Maximum Tolerated Dose
Antibodies
Pharmaceutical Preparations
2 Citations (Scopus)

Prognostic risk score for patients with relapsed or refractory chronic lymphocytic leukaemia treated with targeted therapies or chemoimmunotherapy: a retrospective, pooled cohort study with external validations

Soumerai, J. D., Ni, A., Darif, M., Londhe, A., Xing, G., Mun, Y., Kay, N. E., Shanafelt, T. D., Rabe, K. G., Byrd, J. C., Chanan-Khan, A. A., Furman, R. R., Hillmen, P., Jones, J., Seymour, J. F., Sharman, J. P., Ferrante, L., Mobasher, M., Stark, T., Reddy, V. & 5 others, Dreiling, L. K., Bhargava, P., Howes, A., James, D. F. & Zelenetz, A. D., Jul 1 2019, In : The Lancet Haematology. 6, 7, p. e366-e374

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Cohort Studies
Therapeutics
Survival
Databases
2 Citations (Scopus)

Rapid disease progression following discontinuation of ibrutinib in patients with chronic lymphocytic leukemia treated in routine clinical practice

Hampel, P. J., Ding, W. D., Call, T. G., Rabe, K. G., Kenderian, S., Witzig, T. E., Muchtar, E., Leis, J. F., Chanan Khan, A. A., Koehler, A. B., Fonder, A. L., Schwager, S. M., Slager, S. L., Shanafelt, T. D., Kay, N. E. & Parikh, S. A., Jan 1 2019, In : Leukemia and Lymphoma.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Disease Progression
Clinical Trials
PCI 32765
Therapeutics

Survival trends in glioblastoma and association with treating facility volume

Aulakh, S., DeDeo, M. R., Free, J., Rosenfeld, S., Quinones-Hinojosa, A., Paulus, A., Manna, A., Manochakian, R., Chanan Khan, A. A. & Ailawadhi, S., Jan 1 2019, In : Journal of Clinical Neuroscience.

Research output: Contribution to journalArticle

Glioblastoma
temozolomide
Survival
Therapeutics
Neoplasms

Survival Trends in Young Patients With Multiple Myeloma: A Focus on Racial-Ethnic Minorities

Ailawadhi, S., Azzouqa, A. G., Hodge, D., Cochuyt, J., Jani, P., Ahmed, S., Sher, T., Roy, V., Ailawadhi, M., Alegria, V. R., Manochakian, R., Vishnu, P., Grover, A., Abdulazeez, M. F., Paulus, A. & Chanan Khan, A. A., Jan 1 2019, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Survival
Survival Rate
Hispanic Americans
Epidemiology
1 Citation (Scopus)

Targeting CD38 enhances the antileukemic activity of ibrutinib in chronic lymphocytic leukemia

Manna, A., Aulakh, S., Jani, P., Ahmed, S., Akhtar, S., Coignet, M., Heckman, M., Meghji, Z., Bhatia, K., Sharma, A., Sher, T., Alegria, V., Malavasi, F., Chini, E. N., Chanan Khan, A. A., Ailawadhi, S. & Paulus, A., Jan 1 2019, In : Clinical Cancer Research. 25, 13, p. 3974-3985 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Heterografts
B-Lymphocytes
Antibody-Dependent Cell Cytotoxicity
PCI 32765
1 Citation (Scopus)

Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia

Kumar, V., Ailawadhi, S., Bojanini, L., Mehta, A., Biswas, S., Sher, T., Roy, V., Vishnu, P., Marin-Acevedo, J., Alegria, V. R., Paulus, A., Aulakh, S., Iqbal, M., Manochakian, R., Tan, W., Chanan-Khan, A. & Ailawadhi, M., Oct 1 2019, In : Blood cancer journal. 9, 10, 75.

Research output: Contribution to journalArticle

Open Access
Second Primary Neoplasms
B-Cell Chronic Lymphocytic Leukemia
Survivors
Incidence
Survival Rate
2018
6 Citations (Scopus)

A Phase I Study to Assess the Safety and Pharmacokinetics of Single-agent Lorvotuzumab Mertansine (IMGN901) in Patients with Relapsed and/or Refractory CD–56-positive Multiple Myeloma

Ailawadhi, S., Kelly, K. R., Vescio, R. A., Jagannath, S., Wolf, J., Gharibo, M., Sher, T., Bojanini, L., Kirby, M. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Clinical Lymphoma, Myeloma and Leukemia.

Research output: Contribution to journalArticle

Multiple Myeloma
Pharmacokinetics
Safety
Maximum Tolerated Dose
Clinical Trials, Phase I
7 Citations (Scopus)

Autoimmune cytopenias in patients with chronic lymphocytic leukaemia treated with ibrutinib in routine clinical practice at an academic medical centre

Hampel, P. J., Larson, M. C., Kabat, B., Call, T. G., Ding, W. D., Kenderian, S., Bowen, D., Boysen, J., Schwager, S. M., Leis, J. F., Chanan Khan, A. A., Muchtar, E., Hanson, C. A., Slager, S. L., Kay, N. E., Chaffee, K. G., Shanafelt, T. D. & Parikh, S. A., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Therapeutics
PCI 32765
Natural History
Disease-Free Survival
43 Citations (Scopus)

Daratumumab plus bortezomib and dexamethasone versus bortezomib and dexamethasone in relapsed or refractory multiple myeloma: Updated analysis of CASTOR

Spencer, A., Lentzsch, S., Weisel, K., Avet-Loiseau, H., Mark, T. M., Spicka, I., Masszi, T., Lauri, B., Levin, M. D., Bosi, A., Hungria, V., Cavo, M., Lee, J. J., Nooka, A. K., Quach, H., Lee, C., Barreto, W., Corradini, P., Min, C. K., Scott, E. C. & 17 others, Chanan Khan, A. A., Horvath, N., Capra, M., Beksac, M., Ovilla, R., Jo, J. C., Shin, H. J., Sonneveld, P., Soong, D., Casneuf, T., Chiu, C., Amin, H., Qi, M., Thiyagarajah, P., Sasser, A. K., Schecter, J. M. & Mateos, M. V., Nov 30 2018, In : Haematologica. 103, 12, p. 2079-2087 9 p.

Research output: Contribution to journalArticle

Open Access
Multiple Myeloma
Dexamethasone
Cytogenetics
Disease-Free Survival
History

Impact of psychiatric comorbidities on health care utilization and cost of care in multiple myeloma

Niazi, S., Frank, R. D., Sharma, M., Roy, V., Ames, S., Rummans, T., Spaulding, A., Sher, T., Ailawadhi, M., Bhatia, K., Ahmed, S., Tan, W., Chanan Khan, A. A. & Ailawadhi, S., May 22 2018, In : Blood advances. 2, 10, p. 1120-1128 9 p.

Research output: Contribution to journalArticle

Patient Acceptance of Health Care
Multiple Myeloma
Health Care Costs
Psychiatry
Comorbidity
1 Citation (Scopus)

Improvement of fatigue, physical functioning, and well-being among patients with severe impairment at baseline receiving ibrutinib in combination with bendamustine and rituximab for relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma in the HELIOS study

Cramer, P., Fraser, G., Santucci-Silva, R., Grosicki, S., Dilhuydy, M. S., Janssens, A., Loscertales, J., Rule, S., Goy, A., Traina, S., Chan, E. K. H., Diels, J., Sengupta, N., Mahler, M., Salman, M., Howes, A. & Chanan Khan, A. A., Jan 4 2018, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-10 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Fatigue
Placebos
Quality of Life
Therapeutics
8 Citations (Scopus)

Novel fluorinated curcuminoids and their pyrazole and isoxazole derivatives: Synthesis, structural studies, Computational/Docking and in-vitro bioassay

Laali, K. K., Greves, W. J., Correa-Smits, S. J., Zwarycz, A. T., Bunge, S. D., Borosky, G. L., Manna, A., Paulus, A. & Chanan Khan, A. A., Feb 1 2018, In : Journal of Fluorine Chemistry. 206, p. 82-98 17 p.

Research output: Contribution to journalArticle

Isoxazoles
bioassay
Bioassay
Bearings (structural)
Biological Assay

Outcomes of patients with simultaneous diagnosis of chronic lymphocytic leukaemia/small lymphocytic lymphoma and multiple myeloma

Ailawadhi, S., Dholaria, B. R., Khurana, S., Sher, T., Alegria, V., Paulus, A., Ailawadhi, M., Mehta, A., Chanan Khan, A. A. & Roy, V., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Multiple Myeloma
9 Citations (Scopus)

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Ailawadhi, S., Mikhael, J. R., Laplant, B. R., Laumann, K. M., Kumar, S. K., Roy, V., Dingli, D. M., Bergsagel, P. L., Buadi, F. K., Rajkumar, S. V., Fonseca, R., Gertz, M., Kapoor, P., Sher, T., Hayman, S. R., Stewart, A. K., Dispenzieri, A., Kyle, R. A., Gonsalves, W., Reeder, C. B. & 8 others, Lin, Y., Go, R. S., Leung, N., Kourelis, T., Lust, J. A., Russell, S. J., Chanan Khan, A. A. & Lacy, M., Mar 1 2018, In : Leukemia. 32, 3, p. 719-728 10 p.

Research output: Contribution to journalArticle

Phase II Clinical Trials
Multiple Myeloma
Dexamethasone
Appointments and Schedules
Therapeutics
3 Citations (Scopus)

Synthesis, Computational Docking Study, and Biological Evaluation of a Library of Heterocyclic Curcuminoids with Remarkable Antitumor Activity

Laali, K. K., Greves, W. J., Zwarycz, A. T., Correa Smits, S. J., Troendle, F. J., Borosky, G. L., Akhtar, S., Manna, A., Paulus, A., Chanan Khan, A. A., Nukaya, M. & Kennedy, G. D., Sep 19 2018, In : ChemMedChem. 13, 18, p. 1895-1908 14 p.

Research output: Contribution to journalArticle

Libraries
Cells
Pyrazoles
HCT116 Cells
Cell Line
1 Citation (Scopus)

Targeting CD38 with daratumumab is lethal to Waldenström macroglobulinaemia cells

Paulus, A., Manna, A., Akhtar, S., Paulus, S. M., Sharma, M., Coignet, M. V., Jiang, L., Roy, V., Witzig, T. E., Ansell, S. M., Allan, J., Furman, R., Aulakh, S., Manochakian, R., Ailawadhi, S., Chanan Khan, A. A. & Sher, T., Jan 1 2018, (Accepted/In press) In : British Journal of Haematology.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Cytophagocytosis
Antibodies
B-Lymphocytes
Cell Death
8 Citations (Scopus)

Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities

Ailawadhi, S., Frank, R. D., Sharma, M., Menghani, R., Temkit, M., Paulus, S., Khera, N. D., Hashmi, S., Advani, P., Swaika, A., Paulus, A., Aslam, N., Sher, T., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Costs and Cost Analysis
Survival
Hispanic Americans
19 Citations (Scopus)

Updated results from the phase 3 HELIOS study of ibrutinib, bendamustine, and rituximab in relapsed chronic lymphocytic leukemia/small lymphocytic lymphoma

Fraser, G., Cramer, P., Demirkan, F., Silva, R. S., Grosicki, S., Pristupa, A., Janssens, A., Mayer, J., Bartlett, N. L., Dilhuydy, M. S., Pylypenko, H., Loscertales, J., Avigdor, A., Rule, S., Villa, D., Samoilova, O., Panagiotidis, P., Goy, A., Pavlovsky, M. A., Karlsson, C. & 8 others, Hallek, M., Mahler, M., Salman, M., Sun, S., Phelps, C., Balasubramanian, S., Howes, A. & Chanan Khan, A. A., Jan 1 2018, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Placebos
Disease-Free Survival
PCI 32765
Bendamustine Hydrochloride
15 Citations (Scopus)

Utilization of hematopoietic stem cell transplantation for the treatment of multiple myeloma: a Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) consensus statement

Gonsalves, W., Buadi, F. K., Ailawadhi, S., Bergsagel, P. L., Chanan Khan, A. A., Dingli, D. M., Dispenzieri, A., Fonseca, R., Hayman, S. R., Kapoor, P., Kourelis, T., Lacy, M., Larsen, J. T., Muchtar, E., Reeder, C. B., Sher, T., Stewart, A. K., Warsame, R., Go, R. S., Kyle, R. A. & 14 others, Leung, N., Lin, Y., Lust, J. A., Russell, S. J., Zeldenrust, S. R., Fonder, A. L., Hwa, Y. L., Hobbs, M. A., Mayo, A. A., Hogan, W., Rajkumar, S. V., Kumar, S. K., Gertz, M. & Roy, V., Jul 9 2018, (Accepted/In press) In : Bone Marrow Transplantation. p. 1-15 15 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Multiple Myeloma
Stem Cells
Transplants
Therapeutics
2017
2 Citations (Scopus)

Correlation of sociodemographic and clinical parameters with depression and distress in patients with hematologic malignancies

Shreders, A. J., Niazi, S. K., Hodge, D. O., Chimato, N. T., Kureti, M., Kirla, N., Agrawal, A., Swaika, A., Gustetic, E., Foster, R., Nelson, K. A., Jani, P., Chanan Khan, A. A. & Ailawadhi, S., Dec 7 2017, (Accepted/In press) In : Annals of Hematology. p. 1-10 10 p.

Research output: Contribution to journalArticle

Hematologic Neoplasms
Thermometers
Nonparametric Statistics
Health
Psychiatry
47 Citations (Scopus)
Waldenstrom Macroglobulinemia
Guidelines
Stem Cell Transplantation
Therapeutics
Clinical Trials
4 Citations (Scopus)

Equal Treatment and Outcomes for Everyone with Multiple Myeloma: Are We There Yet?

Ailawadhi, S., Bhatia, K., Aulakh, S., Meghji, Z. & Chanan Khan, A. A., Jun 19 2017, (Accepted/In press) In : Current Hematologic Malignancy Reports. p. 1-8 8 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Delivery of Health Care
Geographic Locations
Insurance Carriers
Vulnerable Populations
15 Citations (Scopus)

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

Bryce, A. H., Egan, J. B., Borad, M. J., Stewart, A. K., Nowakowski, G. S., Chanan Khan, A. A., Patnaik, M. M., Ansell, S. M., Banck, M. S., Robinson, S., Mansfield, A., Klee, E. W., Oliver, G. R., McCormick, J. B., Huneke, N. E., Tagtow, C. M., Jenkins, R. B., Rumilla, K. M., Kerr, S. E., Kocher, J-P. & 5 others, Beck, S. A., Fernandez-Zapico, M. E., Farrugia, G., Lazaridis, K. N. & Mc Williams, R. R., 2017, In : Oncotarget. 8, 16, p. 27145-27154 10 p.

Research output: Contribution to journalArticle

Genomics
Neoplasms
Precision Medicine
Standard of Care
Therapeutics
12 Citations (Scopus)

Lenalidomide maintenance therapy in previously treated chronic lymphocytic leukaemia (CONTINUUM): A randomised, double-blind, placebo-controlled, phase 3 trial

Chanan Khan, A. A., Zaritskey, A., Egyed, M., Vokurka, S., Semochkin, S., Schuh, A., Kassis, J., Simpson, D., Zhang, J., Purse, B. & Foà, R., 2017, (Accepted/In press) In : The Lancet Haematology.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Placebos
Therapeutics
Safety
lenalidomide
4 Citations (Scopus)

Liver dysfunction in chronic lymphocytic leukemia: Prevalence, outcomes, and pathological findings

Hampel, P. J., Chaffee, K. G., King, R., Simonetto, D., Larson, M. C., Achenbach, S., Call, T. G., Ding, W. D., Kenderian, S., Leis, J. F., Chanan Khan, A. A., Bowen, D. A., Conte, M. J., Schwager, S. M., Hanson, C. A., Slager, S. L., Kay, N. E., Shanafelt, T. D. & Parikh, S. A., Dec 1 2017, In : American Journal of Hematology. 92, 12, p. 1362-1369 8 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Liver Diseases
Liver Function Tests
Survival
Liver
9 Citations (Scopus)

Once-weekly ofatumumab in untreated or relapsed Waldenström's macroglobulinaemia: an open-label, single-arm, phase 2 study

Furman, R. R., Eradat, H. A., DiRienzo, C. G., Hofmeister, C. C., Hayman, S. R., Leonard, J. P., Coleman, M., Advani, R., Chanan Khan, A. A., Switzky, J., Liao, Q. M., Shah, D., Jewell, R. C., Lisby, S. & Lin, T. S., Jan 1 2017, In : The Lancet Haematology. 4, 1, p. e24-e34

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Therapeutics
Immunoglobulin M
ofatumumab
Hemolysis
99 Citations (Scopus)

Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL

Ding, W. D., LaPlant, B. R., Call, T. G., Parikh, S. A., Leis, J. F., He, R., Shanafelt, T. D., Sinha, S., Le-Rademacher, J., Feldman, A. L., Habermann, T. M., Witzig, T. E., Wiseman, G. A., Lin, Y., Asmus, E., Nowakowski, G. S., Conte, M. J., Bowen, D. A., Aitken, C. N., Van Dyke, D. L. & 15 others, Greipp, P. T., Liu, X., Wu, X., Zhang, H., Secreto, C. R., Tian, S., Braggio, E. D., Wellik, L. E., Micallef, I., Viswanatha, D. S., Yan, H. D., Chanan Khan, A. A., Kay, N. E., Dong, H. M. & Ansell, S. M., Jun 29 2017, In : Blood. 129, 26, p. 3419-3427 9 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Tumors
Blocking Antibodies
Ligands
pembrolizumab
28 Citations (Scopus)

Pomalidomide, bortezomib, and dexamethasone for patients with relapsed lenalidomide-refractory multiple myeloma

Paludo, J., Mikhael, J. R., Laplant, B. R., Halvorson, A. E., Kumar, S. K., Gertz, M., Hayman, S. R., Buadi, F. K., Dispenzieri, A., Lust, J. A., Kapoor, P., Leung, N., Russell, S. J., Dingli, D. M., Go, R. S., Lin, Y., Gonsalves, W., Fonseca, R., Bergsagel, P. L., Roy, V. & 8 others, Sher, T., Chanan Khan, A. A., Ailawadhi, S., Stewart, A. K., Reeder, C. B., Richardson, P. G., Rajkumar, S. V. & Lacy, M., Sep 7 2017, In : Blood. 130, 10, p. 1198-1204 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Toxicity
Physical vapor deposition
80 Citations (Scopus)

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM

Moreau, P., Chanan Khan, A. A., Roberts, A. W., Agarwal, A. B., Facon, T., Kumar, S. K., Touzeau, C., Punnoose, E. A., Cordero, J., Munasinghe, W., Jia, J., Salem, A. H., Freise, K. J., Leverson, J. D., Enschede, S. H., Ross, J. A., Maciag, P. C., Verdugo, M. & Harrison, S. J., Nov 30 2017, In : Blood. 130, 22, p. 2392-2400 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Refractory materials
Dexamethasone
Myeloid Cell Leukemia Sequence 1 Protein
Safety
11 Citations (Scopus)

Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: A SEER-medicare analysis

Ailawadhi, S., Frank, R. D., Advani, P., Swaika, A., Temkit, M., Menghani, R., Sharma, M., Meghji, Z., Paulus, S., Khera, N. D., Hashmi, S. K., Paulus, A., Kakar, T. S., Hodge, D. O., Colibaseanu, D. T., Vizzini, M. R., Roy, V., Colon-Otero, G. & Chanan Khan, A. A., 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Medicare
Multiple Myeloma
Stem Cells
Thalidomide
Transplants
16 Citations (Scopus)

Randomized phase 3 study of lenalidomide versus chlorambucil as first-line therapy for older patients with chronic lymphocytic leukemia (the ORIGIN trial)

Chanan Khan, A. A., Egyed, M., Robak, T., Martinelli de Oliveira, F. A., Echeveste, M. A., Dolan, S., Desjardins, P., Blonski, J. Z., Mei, J., Golany, N., Zhang, J. & Gribben, J. G., Feb 17 2017, (Accepted/In press) In : Leukemia.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Second primary acute lymphoblastic leukemia in adults: A SEER analysis of incidence and outcomes

Swaika, A., Frank, R. D., Yang, D., Finn, L. E., Jiang, L., Advani, P., Chanan Khan, A. A., Ailawadhi, S. & Foran, J. M., Jan 1 2017, (Accepted/In press) In : Cancer Medicine.

Research output: Contribution to journalArticle

Precursor Cell Lymphoblastic Leukemia-Lymphoma
Epidemiology
Incidence
Survival
Prostate
13 Citations (Scopus)
Waldenstrom Macroglobulinemia
Up-Regulation
Mutation
Therapeutics
Phosphatidylinositol 3-Kinases
2016
39 Citations (Scopus)

Arial fibrillation in patients with chronic lymphocytic leukemia (CLL)

Shanafelt, T. D., Parikh, S. A., Noseworthy, P., Goede, V., Chaffee, K. G., Bahlo, J., Call, T. G., Schwager, S. M., Ding, W. D., Eichhorst, B., Fischer, K., Leis, J. F., Chanan Khan, A. A., Hallek, M., Slager, S. L. & Kay, N. E., Nov 24 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-10 10 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Atrial Fibrillation
Incidence
Heart Valve Diseases
Multivariate Analysis
15 Citations (Scopus)

Coinhibition of the deubiquitinating enzymes, USP14 and UCHL5, with VLX1570 is lethal to ibrutinib- or bortezomib-resistant Waldenstrom macroglobulinemia tumor cells

Paulus, A., Akhtar, S., Caulfield, T., Samuel, K., Yousaf, H., Bashir, Y., Paulus, S. M., Tran, D., Hudec, R., Cogen, D., Jiang, J., Edenfield, B., Novak, A. J., Ansell, S. M., Witzig, T. E., Martin, P., Coleman, M., Roy, V., Ailawadhi, S., Chitta, K. & 2 others, Linder, S. & Chanan Khan, A. A., Nov 4 2016, In : Blood Cancer Journal. 6, 11, e492.

Research output: Contribution to journalArticle

Ubiquitin-Specific Proteases
Waldenstrom Macroglobulinemia
Hydrolases
Ubiquitin
Isoenzymes
496 Citations (Scopus)

Daratumumab, bortezomib, and dexamethasone for multiple myeloma

Palumbo, A., Chanan Khan, A. A., Weisel, K., Nooka, A. K., Masszi, T., Beksac, M., Spicka, I., Hungria, V., Munder, M., Mateos, M. V., Mark, T. M., Qi, M., Schecter, J., Amin, H., Qin, X., Deraedt, W., Ahmadi, T., Spencer, A. & Sonneveld, P., Aug 25 2016, In : New England Journal of Medicine. 375, 8, p. 754-766 13 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Dexamethasone
Disease-Free Survival
Control Groups
Neutropenia
53 Citations (Scopus)

IAP antagonists induce anti-tumor immunity in multiple myeloma

Chesi, M., Mirza, N. N., Garbitt, V. M., Sharik, M. E., Dueck, A., Asmann, Y., Akhmetzyanova, I., Kosiorek, H. E., Calcinotto, A., Riggs, D. L., Keane, N., Ahmann, G. J., Morrison, K. M., Fonseca, R., Lacy, M., Dingli, D. M., Kumar, S. K., Ailawadhi, S., Dispenzieri, A., Buadi, F. & 7 others, Gertz, M., Reeder, C. B., Lin, Y., Chanan Khan, A. A., Stewart, A. K., Fooksman, D. & Bergsagel, P. L., Dec 1 2016, In : Nature Medicine. 22, 12, p. 1411-1420 10 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Tumors
Immunity
Apoptosis
Neoplasms
222 Citations (Scopus)

Ibrutinib combined with bendamustine and rituximab compared with placebo, bendamustine, and rituximab for previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (HELIOS): A randomised, double-blind, phase 3 study

Chanan Khan, A. A., Cramer, P., Demirkan, F., Fraser, G., Silva, R. S., Grosicki, S., Pristupa, A., Janssens, A., Mayer, J., Bartlett, N. L., Dilhuydy, M. S., Pylypenko, H., Loscertales, J., Avigdor, A., Rule, S., Villa, D., Samoilova, O., Panagiotidis, P., Goy, A., Mato, A. & 9 others, Pavlovsky, M. A., Karlsson, C., Mahler, M., Salman, M., Sun, S., Phelps, C., Balasubramanian, S., Howes, A. & Hallek, M., Feb 1 2016, In : The Lancet Oncology. 17, 2, p. 200-211 12 p.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Placebos
Advisory Committees
Disease-Free Survival
Disease Progression
8 Citations (Scopus)

Impact of access to NCI- and NCCN-designated cancer centers on outcomes for multiple myeloma patients: A SEER registry analysis

Ailawadhi, S., Advani, P., Yang, D., Ghosh, R., Swaika, A., Roy, V., Foran, J. M., Colon-Otero, G. & Chanan Khan, A. A., Feb 15 2016, In : Cancer. 122, 4, p. 618-625 8 p.

Research output: Contribution to journalArticle

National Cancer Institute (U.S.)
Multiple Myeloma
Registries
Neoplasms
Survival
12 Citations (Scopus)

Lenalidomide treatment and prognostic markers in relapsed or refractory chronic lymphocytic leukemia: Data from the prospective, multicenter phase-II CLL-009 trial

Bühler, A., Wendtner, C. M., Kipps, T. J., Rassenti, L., Fraser, G. A. M., Michallet, A. S., Hillmen, P., Dürig, J., Gregory, S. A., Kalaycio, M., Aurran-Schleinitz, T., Trentin, L., Gribben, J. G., Chanan Khan, A. A., Purse, B., Zhang, J., De Bedout, S., Mei, J., Hallek, M. & Stilgenbauer, S., Mar 11 2016, In : Blood Cancer Journal. 6, e404.

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Mutation
Therapeutics
Survival
Cytogenetic Analysis
5 Citations (Scopus)

Low expression of pro-apoptotic Bcl-2 family proteins sets the apoptotic threshold in Waldenström macroglobulinemia

Gaudette, B. T., Dwivedi, B., Chitta, K. S., Poulain, S., Powell, D., Vertino, P., Leleu, X., Lonial, S., Chanan Khan, A. A., Kowalski, J. & Boise, L. H., Jan 28 2016, In : Oncogene. 35, 4, p. 479-490 12 p.

Research output: Contribution to journalArticle

Waldenstrom Macroglobulinemia
Apoptosis Regulatory Proteins
Proteins
Cell Line
B-Lymphocytes
14 Citations (Scopus)

Ofatumumab monotherapy as a consolidation strategy in patients with previously untreated chronic lymphocytic leukaemia: a phase 2 trial

Strati, P., Lanasa, M., Call, T. G., Leis, J. F., Brander, D. M., LaPlant, B. R., Pettinger, A. M., Ding, W. D., Parikh, S. A., Hanson, C. A., Chanan Khan, A. A., Bowen, D. A., Conte, M., Kay, N. E. & Shanafelt, T. D., Sep 1 2016, In : The Lancet Haematology. 3, 9, p. e407-e414

Research output: Contribution to journalArticle

B-Cell Chronic Lymphocytic Leukemia
Survival
losoxantrone
Therapeutics
ofatumumab
15 Citations (Scopus)

Pharmacovigilance during ibrutinib therapy for chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) in routine clinical practice

Finnes, H. D., Chaffee, K. G., Call, T. G., Ding, W. D., Kenderian, S., Bowen, D. A., Conte, M., McCullough, K. B., Merten, J. A., Bartoo, G. T., Smith, M. D., Leis, J., Chanan Khan, A. A., Schwager, S. M., Slager, S. L., Kay, N. E., Shanafelt, T. D. & Parikh, S. A., Nov 7 2016, (Accepted/In press) In : Leukemia and Lymphoma. p. 1-8 8 p.

Research output: Contribution to journalArticle

Pharmacovigilance
B-Cell Chronic Lymphocytic Leukemia
Cytochrome P-450 CYP3A
Therapeutics
Clinical Trials